Healthcare

Medpace runs clinical trials for drug and biotech companies through a focused full-service model. Strong margins, rising cash flow, and deep therapeutic expertise make it a standout operator in healthcare services and a business worth a closer look.

Madrigal Pharmaceuticals is building around Rezdiffra, one of the first approved medicines for MASH. Revenue growth has been strong, the market opportunity is large, and early commercial positioning is meaningful, making the company an important name to examine in liver disease.

Jazz Pharmaceuticals sells specialized medicines in sleep disorders, epilepsy, and oncology. Strong cash generation, high margins, and a revenue mix shifting toward newer products make it an increasingly substantial healthcare business worth examining in depth.

ICON runs clinical trials and research services for drug developers worldwide. Its global scale, broad outsourcing platform, and strong cash generation stand out, while the central question is whether recent earnings pressure fades as demand and margins improve.